RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vistin Pharma A Stock

Vistin Pharma A Debt 2024

Vistin Pharma A Debt

0 NOK

Ticker

VISTN.OL

ISIN

NO0010734122

WKN

A14TLR

In 2024, Vistin Pharma A's total debt was 0 NOK, a -100% change from the 47.7 NOK total debt recorded in the previous year.

Vistin Pharma A Aktienanalyse

What does Vistin Pharma A do?

Vistin Pharma ASA is a Norwegian company specializing in the production and sale of chemical products. The company was founded in 1997 and is headquartered in Oslo. History: The company started as a chemical products manufacturer but quickly began focusing on the production of pharmaceutical products and active ingredients in the early 2000s. In 2016, the subsidiary Vistin Pharma Production AS was established, specializing in the production of active ingredients for the chemical industry. Business model: Vistin Pharma is a niche provider of specialized chemical and pharmaceutical products. The company focuses on producing high-quality products for selected markets and industries where it has a competitive position. The business model is based on a combination of advanced research and development, state-of-the-art production facilities, and a comprehensive network of sales partners and distributors. Different divisions: Vistin Pharma's business activities mainly focus on two main divisions: Pharmaceuticals and Industrial Active Ingredients. The Pharmaceuticals division includes the production and sale of active ingredients for the production of human and animal health medications. The products include Metformin, an active ingredient for treating diabetes, as well as Methotrexate tablets for cancer treatment. The Industrial Active Ingredients division produces active ingredients for various industries, including cosmetics, food, and energy sectors. Products: One of Vistin Pharma's best-known products is Metformin, an orally administered medication for treating type 2 diabetes. Metformin helps control and lower blood sugar levels by preventing the liver from producing too much glucose and improving the body's sensitivity to insulin. Vistin Pharma's Methotrexate tablets are used to treat a variety of cancers, including breast cancer, lung cancer, and leukemia. Overall, Vistin Pharma offers a wide range of chemical and pharmaceutical products suitable for various applications. The company places great emphasis on quality and sustainability and strives to offer its customers high-quality and environmentally friendly products and services. Conclusion: Vistin Pharma is an innovative Norwegian pharmaceutical and chemical company that has been focused on producing and selling high-quality products since its inception. With a wide range of chemical and pharmaceutical products and a strong focus on research and development, product quality, and sustainability, Vistin Pharma is well-positioned to continue growing and establish itself as a leading provider in its core markets. The output translation is: Vistin Pharma ASA is a Norwegian company specializing in the production and sale of chemical and pharmaceutical products. It was founded in 1997 and is headquartered in Oslo. The company has expanded from being a chemical products manufacturer to producing pharmaceutical products and active ingredients. It operates through two main divisions: Pharmaceuticals and Industrial Active Ingredients. Vistin Pharma's products include Metformin for treating diabetes and Methotrexate tablets for cancer treatment. The company focuses on providing high-quality and environmentally friendly products and services. With its strong emphasis on research and development, product quality, and sustainability, Vistin Pharma aims to become a leading player in its core markets. Vistin Pharma A ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Vistin Pharma A's Debt Structure

Vistin Pharma A's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Vistin Pharma A's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Vistin Pharma A’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Vistin Pharma A’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Vistin Pharma A stock

What is the debt of Vistin Pharma A this year?

Vistin Pharma A has a debt level of 0 NOK this year.

What was the debt of Vistin Pharma A compared to the previous year?

The debt of Vistin Pharma A has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in Vistin Pharma A?

High debt can pose a risk for investors of Vistin Pharma A, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Vistin Pharma A?

Low debt means that Vistin Pharma A has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Vistin Pharma A affect the company?

An increase in debt of Vistin Pharma A can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Vistin Pharma A affect the company?

A reduction in debt of Vistin Pharma A can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Vistin Pharma A?

Some factors that can influence the debt of Vistin Pharma A include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Vistin Pharma A so important for investors?

The debts of Vistin Pharma A are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Vistin Pharma A take to change the debt?

To change the debt, Vistin Pharma A can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Vistin Pharma A pay?

Over the past 12 months, Vistin Pharma A paid a dividend of 0.75 NOK . This corresponds to a dividend yield of about 2.87 %. For the coming 12 months, Vistin Pharma A is expected to pay a dividend of 0.75 NOK.

What is the dividend yield of Vistin Pharma A?

The current dividend yield of Vistin Pharma A is 2.87 %.

When does Vistin Pharma A pay dividends?

Vistin Pharma A pays a quarterly dividend. This is distributed in the months of June, February, July, December.

How secure is the dividend of Vistin Pharma A?

Vistin Pharma A paid dividends every year for the past 0 years.

What is the dividend of Vistin Pharma A?

For the upcoming 12 months, dividends amounting to 0.75 NOK are expected. This corresponds to a dividend yield of 2.87 %.

In which sector is Vistin Pharma A located?

Vistin Pharma A is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vistin Pharma A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vistin Pharma A from 11/19/2024 amounting to 0.5 NOK, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Vistin Pharma A pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Vistin Pharma A in the year 2023?

In the year 2023, Vistin Pharma A distributed 0.5 NOK as dividends.

In which currency does Vistin Pharma A pay out the dividend?

The dividends of Vistin Pharma A are distributed in NOK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vistin Pharma A

Our stock analysis for Vistin Pharma A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vistin Pharma A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.